ETERNITY HEALTHCARE INC. (OTCMKTS:ETAH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02
|
Departure of Directors or Principal Officers; Election of |
May 15, 2017 – Eternity Healthcare Inc. a Nevada Corporation
(OTCBB: ETAH) (the Company), today announced that two board
members have resigned. Mr. Dominique Borrelly and Mrs. Bin Huang
have provided their resignation to Dr. Hassan Salari, Chairman,
CEO and Board member. At the board meeting, our directors and
sole officer considered their resignations, fiduciary duties and
general circumstances and reasons for the resignations, including
the actions undertaken over the past years to manage, oversee and
monitor the Companys business in such difficult and adverse
conditions. Both members expressed their concerns on the
financial status of the Company and its future ability to
compensate the board members, any required consultants and the
general operation of the Company. Having a healthy financial
balance sheet is important and if not addressed properly may
cause the delay in product development, delay in regulatory
approval, or total insolvency. However, the management believes
it has several options to consider. These include rights offering
to current shareholders, merger acquisition or the Company
ceasing its reporting obligations all together and/or operating
as a private company.
About ETERNITY HEALTHCARE INC. (OTCMKTS:ETAH)
Eternity Healthcare Inc. is a medical device company. The Company is engaged in the discovery, development and marketing of medical devices. The Company is focused on marketing of its needle-free injection device technology. It also includes an over the counter pain treatment device using laser as treatment source. Its products include Nozzles/syringes, Adapters, Nozzle/Adapter Combination Pack and Adapters (Large). The Company’s products are sold to healthcare professionals for use in physicians’ offices, pharmacies and to all consumers. It provides delivery technologies for insulin, human chorionic gonadotropin (hCG), human growth hormone (hGH), Vitamin B12, vaccines, anesthetics, migraine medication and steroids. The Company provides a soft injection system that avoids the use of needles for the delivery of various sorts of injectable medications, including cancer medication. It is a universal injection system that can deliver medication in both pediatrics and adults. ETERNITY HEALTHCARE INC. (OTCMKTS:ETAH) Recent Trading Information
ETERNITY HEALTHCARE INC. (OTCMKTS:ETAH) closed its last trading session up +0.0014 at 0.0351 with 9,435 shares trading hands.